openPR Logo
Press release

Global Intracranial Stents Market 2024 : SWOT Analysis Of Key Driving Factors For Growing CAGR Value | Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation

05-13-2024 09:18 AM CET | Health & Medicine

Press release from: The Business Research Company

Intracranial Stents Global Market Report 2024

Intracranial Stents Global Market Report 2024

"The intracranial stents market size has grown rapidly in recent years. It will grow from $0.42 billion in 2023 to $0.49 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increased awareness of stroke risks, improved patient education, rise in radiation safety measures, increased aging population, emergence of minimally invasive techniques.

The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $0.87 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of genomic medicine, rising healthcare infrastructure, expansion of stroke rehabilitation services, rising health initiatives. Major trends in the forecast period include adoption of bioresorbable intracranial stents, adoption of neurointerventional robotics, integration of advanced imaging technologies, adoption of pediatric intracranial stents, developing dual antiplatelet therapy strategies.

Market Overview -
Intracranial stents are tubular device that is placed inside the blood vessel, canal, or duct. They are used for intracranial stenosis and brain aneurysms to open the blocked arteries.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=5169&type=smp

Rising Incidence Of Brain Aneurysms Boosts Growth In The Intracranial Stents Market
The increase in incidence of a brain aneurysm is expected to propel the growth of the intracranial stents market in the coming years. A brain aneurysm is the development of a bulge in the blood vessels of the brain. This bulge may rupture or burst and can cause brain haemorrhage, which may lead to the death of the patient. Intracranial vessel stenting (IVS) is a minimally invasive treatment for treating serious cerebral artery stenosis. The weakening of the arteries that deliver blood to the brain is known as cerebral artery stenosis. For instance, in February 2023, according to the Medical News Today, a UK-based medical news website, about 3.2% of persons worldwide have unruptured aneurysms. Thus, the increasing incidence of a brain aneurysm will drive the intracranial stents market growth.

Competitive Landscape -
Major companies operating in the intracranial stents market include Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention Inc., Phenox GmbH, Terumo Corporation, Johnson & Johnson Services Inc., Abbott Laboratories, Brainlab AG, Cardiatis SA, Cook Medical LLC, DePuy Synthes, Endologix Inc., InspireMD Inc., Integra LifeSciences Corporation, Kaneka Corporation, Kerecis Limited, Penumbra Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Codman Neuro, C.R. Bard Inc., Cerebral Stents.

Innovative Onyx Frontier Drug-Eluting Stent Revolutionizes The Intracranial Stents Market
Major companies operating in the intracranial stents market are innovating new products such as Onyx Frontier drug-eluting stent (DES) to increase their profitability in the market. Onyx Frontier is a drug-eluting stent (DES) used to treat coronary artery disease (CAD), which is brought on by plaque accumulation inside the coronary arteries. For instance, in August 2022, Medtronic plc, an Ireland-based medical devices company launched Onyx Frontier drug-eluting stent (DES). The stent's architecture makes it ideal for sophisticated percutaneous cardiac intervention (PCI) and is highly deliverable. The Resolute Onyx DES's acute performance and clinical data provide the foundation for the Onyx Frontier DES, which provides a better delivery mechanism and greater acute performance.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Key Segments -
The intracranial stents market covered in this report is segmented -
1) By Type: Self Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization
2) By Disease Indication: Brain Aneurysm, Intracranial Stenosis
3) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Intracranial Stents Market 2024 : SWOT Analysis Of Key Driving Factors For Growing CAGR Value | Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation here

News-ID: 3493917 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Technologies In Surgical Energy Instruments as a Key Influencer
Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Surgical Energy Instruments Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the market size of surgical energy instruments has seen substantial growth. The market which is projected to be worth $4.68 billion in 2024, is expected to inflate to $5.2
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Spatial omics Market Through 2025? In recent years, the size of the spatial omics market has seen rapid expansion. The estimations show an increase to $0.33 billion in 2025 from $0.3 billion in 2024, marking a compound annual growth rate (CAGR) of
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billion by 2029
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Sigmoidoscope Industry Market Size Be by 2025? In recent years, there has been a significant increase in the size of the sigmoidoscope market. The market is projected to expand from $2.53 billion in 2024 to $2.67 billion in 2025, demonstrating a compound annual growth rate (CAGR)
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advantage
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Refurbished MRI Systems Market Size By 2025? The market size for refurbished MRI systems has experienced robust growth in the past few years. It is expected to rise from $0.77 billion in 2024 to $0.85 billion in 2025, showcasing a compound annual growth rate (CAGR)

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients